These early benefits are primarily from the B vitamin and L-Carnitine components
acknowledges support from the NIH (R37CA240625, R01CA259111, R01CA298386, P30CA010815 and P30CA047904), the Sandy Rollman Ovarian Cancer Foundation, the American Cancer Society (RSG-19-113-01-CCG), the Congressionally Directed Medical Research Program (HT9425-23-1-0436), the UPMC Hillman Cancer Center and the Wistar Institute
Your doctor will monitor your progress
These signs should be immediately reported to your doctor
Evaluation of the effect of intravenous L-carnitine therapy on function, structure and fatty acid metabolism of skeletal muscle in patients receiving chronic hemodialysis
However, this effect is transient and reversed upon discontinuation of therapy, and the long-term risk-benefit analysis of its administration is still unclear